STATE OF MINNESOTA FIFTY-SIXTH MEETING
HOUSE OF REPRESENTATIVES NINETY-SECOND SESSION
HEALTH FINANCE AND POLICY COMMITTEE
Representative Tina Liebling, Chair of the Committee, called the virtual Health Finance and Policy Committee meeting to order at 3:00 P.M. on March 9, 2022 pursuant to House rule 10.01. The meeting is being broadcast via Zoom and House Public Information Services.
The Committee Legislative Assistant noted the roll.
LIEBLING, Tina, Chair
HUOT, John, Vice Chair
SCHOMACKER, Joe, Minority Lead
A quorum was present.
Representative Bierman moved that the minutes of March 8, 2022 be approved. THE MOTION PREVAILED.
HF3717 (Stephenson) Minnesota premium security plan operation extended, and money transferred.
Chair Liebling moved that HF3717, First Engrossment, be re-referred to the Committee on Ways and Means.
Representative Stephenson presented his bill.
1. Bentley Graves, Health Care and Transportation Policy, Minnesota Chamber of
2. Dan Endresen, Senior Director of Policy and Government Affairs, Minnesota Council of Health Plans
Peter Brickwedde, Assistant Commissioner, Government and External Affairs, Minnesota Department of Commerce, responded to member questions.
Representative Morrison moved the H3717A11 Amendment. Chair Liebling instructed staff to make the necessary technical corrections. THE MOTION PREVAILED AND THE AMENDMENT, AS CORRECTED, WAS ADOPTED.
Representative Bierman moved the H3717A16 Amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.
Representative Schultz moved the H3717A15 Amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.
Chair Liebling renewed her motion that HF3717, First Engrossment, as amended, be re-referred to the Committee on Ways and Means. The Chair stated there would be a roll call vote. The results were as follows:
On a vote of 11 AYES and 7 NAYS THE MOTION PREVAILED.
HF3786 (Bierman) Intractable pain definition modified, and controlled substance prescription for treatment criteria modified.
Representative Bierman moved that HF3786 be laid over for possible inclusion in the Health Finance and Policy Committee bill.
Representative Bierman moved the H3786A1 Amendment. THE MOTION PREVAILED AND THE AMENDMENT WAS ADOPTED.
Representative Bierman and Representative Baker presented the bill.
1. Dr. Beth Darnall, Director, Stanford Pain Relief Innovations Lab
2. Dr. David Schultz, Founder and CEO, Nura Pain Clinics
3. Dr Todd Hess, Medical Director, United Pain Center
4. Rae Blaylark, President & CEO, Sickle Cell Foundation of Minnesota
Chair Liebling laid over HF3786, as amended, possible inclusion in the Committee bill.
The meeting was adjourned at 4:28 P.M.
Representative Tina Liebling, Chair
Krysta Niedernhöfer, Committee Legislative Assistant